19-49130055-T-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The NM_003660.4(PPFIA3):āc.645T>Gā(p.Asp215Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000181 in 1,612,472 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003660.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPFIA3 | NM_003660.4 | c.645T>G | p.Asp215Glu | missense_variant | 6/30 | ENST00000334186.9 | NP_003651.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPFIA3 | ENST00000334186.9 | c.645T>G | p.Asp215Glu | missense_variant | 6/30 | 1 | NM_003660.4 | ENSP00000335614.3 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152008Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000962 AC: 24AN: 249436Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135044
GnomAD4 exome AF: 0.000186 AC: 272AN: 1460346Hom.: 0 Cov.: 31 AF XY: 0.000178 AC XY: 129AN XY: 726614
GnomAD4 genome AF: 0.000131 AC: 20AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74392
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | The c.645T>G (p.D215E) alteration is located in exon 6 (coding exon 5) of the PPFIA3 gene. This alteration results from a T to G substitution at nucleotide position 645, causing the aspartic acid (D) at amino acid position 215 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at